New Details on the Revision of USP Chapter 1
Recommendation

29/30 September 2026
Solutions for the Pharmaceutical Industry
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
23.09.2026FDA criticises Visual Inspection
09.09.2026What is meant by Good Engineering Practice in the Pharmaceutical Industry?
02.09.2026New Q&A Document on Visual Inspection of Parenterals
02.09.2026What are the Requirements for GMP-compliant Water Systems?
26.08.2026Who has to sign a URS?

